J0895 HCPCS Level II code: Injection, deferoxamine mesylate, 500 mg
J0895 is the HCPCS code for “Injection, deferoxamine mesylate, 500 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0895Injection, deferoxamine mesylate, 500 mg
Short description: Deferoxamine mesylate inj
HCPCS · United States
Medicare details
The indicators CMS publishes with J0895 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Cross-reference
- See Q0087
- Added
- Jan 1, 1992
Where J0895 sits
- 1J codesDrugs administered other than orally
- 2Active code J0895Injection, deferoxamine mesylate, 500 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0895 mean?
J0895 is the HCPCS code for “Injection, deferoxamine mesylate, 500 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0895?
CMS lists J0895’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0895
All J codesJ0889Daprodustat, oral, 1 mg, (for esrd on dialysis)J0890Injection, peginesatide, 0.1 mg (for esrd on dialysis)J0891Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)J0892Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)J0893Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mgJ0894Injection, decitabine, 1 mgJ0896Injection, luspatercept-aamt, 0.25 mgJ0897Injection, denosumab, 1 mgJ0898Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)J0899Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)J0900Injection, testosterone enanthate and estradiol valerate, up to 1 ccJ0901Vadadustat, oral, 1 mg (for esrd on dialysis)